Naoko Utsunomiya-Tate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Naoko Utsunomiya-Tate has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Genta Ito
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo, Japan
3 shared publications Takuya Murata
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, 173-8605, Japan
3 shared publicationsNaoya Tochio
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo 173-8605, Japan
2 shared publications- Takuya Murata
Department of Biomolecular Chemistry, Faculty of Pharmaceutical Sciences, Teikyo University, Tokyo 173-8605, Japan
2 shared publications - Mitsunori Fukuda
Tohoku University
1 shared publication - Noriko Isoo
Department of Physiology, School of Medicine, Teikyo University, Tokyo 173-8605, Japan
1 shared publication
Latest Publications
- Open Access
- 13 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 143
Site-Specific Aspartic Acid d-Isomerization in Tau R2 and R3 Peptide Seeds Attenuates Seed-Induced Fibril Formation of Full-Length Tau
The aggregation of tau protein is a central pathological event in Alzheimer’s disease, and this pathology is hypothesized to spread via a prion-like mechanism driven by tau “seeds”. While aggregated tau from Alzheimer’s disease brains is known to contain age-related d-isomerized aspartic acid (d-Asp) residues, it remains unknown how this modification affects the seeding activity that drives disease propagation. Here, we investigated the impact of site-specific d-isomerization within R2 and R3 tau repeat-domain peptides, which form the core of tau fibrils. We demonstrate that the stereochemical integrity of these peptides is critical for their seeding function. d-isomerization at Asp314 within the R3 peptide seed severely impaired its ability to template the fibrillization of full-length tau in vitro. This finding was validated in a cellular model, where R3 seeds containing d-Asp314 were significantly less potent at inducing the formation of phosphorylated tau aggregates compared to wild-type seeds. Our results establish that Asp d-isomerization within tau seeds acts as a potent attenuator of their pathological seeding activity, suggesting this spontaneous modification may intrinsically modulate the progression of Alzheimer’s disease.
- 13 January 2026
- Published by MDPI AG in Biomolecules
- Vol. 16 (1) , 143
Open AccessSite-Specific Aspartic Acid d-Isomerization in Tau R2 and R3 Peptide Seeds Attenuates Seed-Induced Fibril Formation of Full-Length Tau
The aggregation of tau protein is a central pathological event in Alzheimer’s disease, and this pathology is hypothesized to spread via a prion-like mechanism driven by tau “seeds”. While aggregated tau from Alzheimer’s disease brains is known to contain age-related d-isomerized aspartic acid (d-Asp) residues, it remains unknown how this modification affects the seeding activity that drives disease propagation. Here, we investigated the impact of site-specific d-isomerization within R2 and R3 tau repeat-domain peptides, which form the core of tau fibrils. We demonstrate that the stereochemical integrity of these peptides is critical for their seeding function. d-isomerization at Asp314 within the R3 peptide seed severely impaired its ability to template the fibrillization of full-length tau in vitro. This finding was validated in a cellular model, where R3 seeds containing d-Asp314 were significantly less potent at inducing the formation of phosphorylated tau aggregates compared to wild-type seeds. Our results establish that Asp d-isomerization within tau seeds acts as a potent attenuator of their pathological seeding activity, suggesting this spontaneous modification may intrinsically modulate the progression of Alzheimer’s disease.
- Open Access
- 16 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 845
Overview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s Disease
Leucine-rich repeat kinase 2 (LRRK2) is a large protein kinase that physiologically phosphorylates and regulates the function of several Rab proteins. LRRK2 is genetically implicated in the pathogenesis of both familial and sporadic Parkinson’s disease (PD), although the underlying mechanism is not well understood. Several pathogenic mutations in the LRRK2 gene have been identified, and in most cases the clinical symptoms that PD patients with LRRK2 mutations develop are indistinguishable from those of typical PD. However, it has been shown that the pathological manifestations in the brains of PD patients with LRRK2 mutations are remarkably variable when compared to sporadic PD, ranging from typical PD pathology with Lewy bodies to nigral degeneration with deposition of other amyloidogenic proteins. The pathogenic mutations in LRRK2 are also known to affect the functions and structure of LRRK2, the differences in which may be partly attributable to the variations observed in patient pathology. In this review, in order to help researchers unfamiliar with the field to understand the mechanism of pathogenesis of LRRK2-associated PD, we summarize the clinical and pathological manifestations caused by pathogenic mutations in LRRK2, their impact on the molecular function and structure of LRRK2, and their historical background.
- 16 May 2023
- Published by MDPI AG in Biomolecules
- Vol. 13 (5) , 845
Open AccessOverview of the Impact of Pathogenic LRRK2 Mutations in Parkinson’s Disease
Leucine-rich repeat kinase 2 (LRRK2) is a large protein kinase that physiologically phosphorylates and regulates the function of several Rab proteins. LRRK2 is genetically implicated in the pathogenesis of both familial and sporadic Parkinson’s disease (PD), although the underlying mechanism is not well understood. Several pathogenic mutations in the LRRK2 gene have been identified, and in most cases the clinical symptoms that PD patients with LRRK2 mutations develop are indistinguishable from those of typical PD. However, it has been shown that the pathological manifestations in the brains of PD patients with LRRK2 mutations are remarkably variable when compared to sporadic PD, ranging from typical PD pathology with Lewy bodies to nigral degeneration with deposition of other amyloidogenic proteins. The pathogenic mutations in LRRK2 are also known to affect the functions and structure of LRRK2, the differences in which may be partly attributable to the variations observed in patient pathology. In this review, in order to help researchers unfamiliar with the field to understand the mechanism of pathogenesis of LRRK2-associated PD, we summarize the clinical and pathological manifestations caused by pathogenic mutations in LRRK2, their impact on the molecular function and structure of LRRK2, and their historical background.
- 1 August 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 760, 136077
Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity
- 1 August 2021
- Published by Elsevier in Neuroscience Letters
- Vol. 760, 136077
Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity
- Open Access
- 1 September 2020
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 23, 100776
The dynamic structure of Rab35 is stabilized in the presence of GTP under physiological conditions
- 1 September 2020
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 23, 100776
Open AccessThe dynamic structure of Rab35 is stabilized in the presence of GTP under physiological conditions
- 1 January 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 508 (1) , 184-190
Effect of site-specific amino acid D-isomerization on β-sheet transition and fibril formation profiles of Tau microtubule-binding repeat peptides
- 1 January 2019
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 508 (1) , 184-190
Effect of site-specific amino acid D-isomerization on β-sheet transition and fibril formation profiles of Tau microtubule-binding repeat peptides